Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunling Hu

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Frontiers in Pharmacology|November 22, 2021
Integrating Network Pharmacology, Transcriptome and Artificial Intelligence for Investigating Into the Effect and Mechanism of Ning Fei Ping Xue Decoction Against the Acute Respiratory Distress SyndromeXiaoxiao Lu, Wentao Ma, Baofeng Fan, et al.
Frontiers in Immunology|May 13, 2022
Tanreqing Injection Attenuates Macrophage Activation and the Inflammatory Response <i>via</i> the lncRNA-SNHG1/HMGB1 Axis in Lipopolysaccharide-Induced Acute Lung InjuryChunling Hu, Junlu Li, Yingshuai Tan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
JCO Precision Oncology|September 14, 2020
Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical OutcomeSiddhartha Yadav, Steven N Hart, Chunling Hu, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Genes, Chromosomes & Cancer|November 25, 2010
Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survivalJu Dong Yang, Zhifu Sun, Chunling Hu, et al.
Journal of Alzheimer'S Disease Reports|July 24, 2018
Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell SignalingRosebud O Roberts, Yoo Na Kang, Chunling Hu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 21, 2015
Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer PatientsChunling Hu, Steven N Hart, William R Bamlet, et al.
Gynecologic Oncology|January 8, 2019
Cancer susceptibility gene mutations in type I and II endometrial cancerBeverly Long, Jenna Lilyquist, Amy Weaver, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitorsJin-Ping Lai, Dalbir S Sandhu, Chunrong Yu, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Frontiers in Pharmacology|November 22, 2021
Integrating Network Pharmacology, Transcriptome and Artificial Intelligence for Investigating Into the Effect and Mechanism of Ning Fei Ping Xue Decoction Against the Acute Respiratory Distress SyndromeXiaoxiao Lu, Wentao Ma, Baofeng Fan, et al.
Frontiers in Immunology|May 13, 2022
Tanreqing Injection Attenuates Macrophage Activation and the Inflammatory Response <i>via</i> the lncRNA-SNHG1/HMGB1 Axis in Lipopolysaccharide-Induced Acute Lung InjuryChunling Hu, Junlu Li, Yingshuai Tan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2023
Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based CohortsJoanne Kotsopoulos, Cassandra A Hathaway, Steven A Narod, et al.
JCO Precision Oncology|September 14, 2020
Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical OutcomeSiddhartha Yadav, Steven N Hart, Chunling Hu, et al.
Gynecologic Oncology|September 11, 2017
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controlsJenna Lilyquist, Holly LaDuca, Eric Polley, et al.
Genes, Chromosomes & Cancer|November 25, 2010
Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survivalJu Dong Yang, Zhifu Sun, Chunling Hu, et al.
Journal of Alzheimer'S Disease Reports|July 24, 2018
Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell SignalingRosebud O Roberts, Yoo Na Kang, Chunling Hu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 21, 2015
Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer PatientsChunling Hu, Steven N Hart, William R Bamlet, et al.
Gynecologic Oncology|January 8, 2019
Cancer susceptibility gene mutations in type I and II endometrial cancerBeverly Long, Jenna Lilyquist, Amy Weaver, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2010
Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitorsJin-Ping Lai, Dalbir S Sandhu, Chunrong Yu, et al.
Pageof 14